Navigation Links
US Appeals Court opens federal funding for stem cell research
Date:4/29/2011

The U.S. Federal Court of Appeals has overturned an August 2010 ban on federal funding of embryonic stem cell research, paving the way for broader exploration of how stem cells function and how they can be harnessed to treat a wide range of currently incurable diseases.

The ruling has been welcomed by the Obama Administration, which attempted to lift the ban in 2009, and by the nation's top researchers in the field, including Arnold Kriegstein, MD, PhD, director of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF.

"This is a victory not only for the scientists, but for the patients who are waiting for treatments and cures for terrible diseases," Kriegstein said. "This ruling allows critical research to move forward, enabling scientists to compare human embryonic stem cells to other forms of stem cells, such as the cell lines which are derived from skin cells, and to pursue potentially life-saving therapies based on that research."

Kriegstein said the ruling will make a significant difference for stem cell research in general, including at UCSF, where the majority of stem cell investigators receive some funding from the National Institutes of Health for their research, as well as from private sources and from the state. The ruling enables those scientists to integrate research from various funding sources, thereby more quickly addressing the causes and therapies for diseases.

Kriegstein was one of two University of California scientists to file a Declaration in September 2010 in support of the UC Board of Regents' motion to intervene in the August lawsuit, Sherley v. Sebelius.

Sherly v. Sebelius had argued that when the Obama Administration lifted a ban on federal funding for the research in March 2009, it had violated the 1996 Dickey-Wicker Amendment which barred using taxpayer funds in research that destroyed embryos.

In response, a U.S. District Court judge temporaril
'/>"/>

Contact: Kristen Bole
kristen.bole@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert

Page: 1 2

Related biology news :

1. Spiders adjust courtship signals for maximum effect
2. Texas A&M study finds courtship affects gene expression in flies
3. A love game: Fish courtship more complex than thought
4. IEEE-USA pleased that Supreme Courts ruling preserves software patents
5. U.S. Supreme Court Allows Coercive Confinement to Continue in Attorneys Civil Contempt Case
6. Urine sprays during courtship send mixed messages
7. Male Australian redback spiders employ courtship strategies to preserve their life
8. Nematode courting caught on camera
9. BIO-key to Respond in Court to a Lawsuit Filed by Two Investors
10. Advance in microchannel manufacturing opens new industry applications
11. The University of Montreal Biodiversity Centre opens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:12/3/2014)... -- As part of our commitment to offering the ... announce the release of a new reader that will ... data that they need. The Atlas 2000 ... readers. Many such devices have serious shortcomings when it ... models force users to navigate numerous complicated steps in ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
... may have found a way to dramatically slow organ ... That's the promising implication of an animal study carried ... Birmingham (UAB) and the University of Florida (UF) published ... National Academy of Sciences. , The research team reported ...
... A drug first used to reduce the risk of stomach ... alternative to surgery after miscarriage, according to a study by ... Development of the National Institutes of Health and other research ... New England Journal of Medicine. , The drug, misoprostol, has ...
... protein design by a University of Houston professor will ... Nano Summit Research Conference July 28. , Kurt L. ... UH, will give a presentation at 11 a.m. on ... by the Nanotechnology Foundation of Texas, the 2005 Nano ...
Cached Biology News:Discoveries by UAB and Florida scientists may help transplanted organs survive longer 2Drug Offers Alternative to Surgical Treatment After Miscarriage 2Drug Offers Alternative to Surgical Treatment After Miscarriage 3Drug Offers Alternative to Surgical Treatment After Miscarriage 4Disease diagnosis, bioengineering covered at state nano summit 2
(Date:12/22/2014)... , Dec. 22, 2014   Synthetic ... developer of pathogen-specific therapies for serious infections ... the microbiome, today announced positive topline safety ... clinical trial of SYN-004, the Company,s investigational ... Clostridium difficile (C. difficile) infection, ...
(Date:12/22/2014)... Calif. , Dec. 22, 2014  ( www.competitivehealth.com ... CoPatient, an online medical bill review and advocacy service, ... in the FREE WellCard Savings discount health services marketplace. ... bill that was more than they expected to pay. ... reduce health care costs, WellCard Savings is pleased to ...
(Date:12/19/2014)... December 19, 2014 Bioject Medical ... and manufacturer of needle-free injection technology, today announced ... Immunomic Therapeutics, Inc. (“ITI”) for ITI to use ... its LAMP™ vaccine platform. , In the ... Worldwide license to the Biojector®-2000 that triggers based ...
(Date:12/19/2014)... PLEASANTON, Calif. , Dec. 19, 2014  Roche ... acquisition of Bina Technologies, Inc. (Bina), a privately ... California , USA. Bina provides a big ... next generation sequencing (NGS) data. Bina,s proprietary on-market ... translational and academic researchers to perform fast and ...
Breaking Biology Technology:Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3
... PALO ALTO, Calif., Oct. 26 Telik, Inc. (Nasdaq: ... HCl), the company,s lead therapeutic product candidate, has been ... of "The Top 10 Most Interesting Oncology Projects to ... to senior executives in the pharmaceutical, biotechnology, and medical ...
... Genomic Health , Inc. (Nasdaq: GHDX ) ... webcast on Monday, November 8 at 4:30 p.m. Eastern Time to ... will follow the release of the third quarter financial results after ... To access the live conference call on November 8 ...
... Pharmaceuticals, Inc. (Nasdaq: OPTR ) is scheduled ... the Waldorf-Astoria Hotel in New York City on Tuesday, ... (Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO ) (Logo: ... presentation will be accessible on the Company,s website at ...
Cached Biology Technology:TELINTRA® Named One of the 10 Most Interesting Oncology Projects to Watch 2TELINTRA® Named One of the 10 Most Interesting Oncology Projects to Watch 3Genomic Health to Announce Third Quarter 2010 Financial Results and Host Conference Call on Monday, November 8, 2010 2Optimer Pharmaceuticals to Present at Oppenheimer Healthcare Conference 2
... Kit provides a fast and simple procedure for ... buffer exchange, and for removing different types of ... on spin-column chromatography using Norgens patented protein resin ... 2 , NaCl, KCl, CaCl 2 , LiCl, ...
... Surveyor software provides local instrument control ... HPLC Systems. The software operates on ... Windows Pocket PC 2002 O/S and ... directly to their Surveyor quaternary gradient ...
... Kit is a very sensitive immunohistochemical tool ... containing both anti-von Willebrand Factor and anti-CD31 ... variety of species. This AP kit provides ... of frozen and paraffin-embedded sections in human ...
... and MDS Sciex present the 4000 ... performance hybrid triple quadrupole/linear ion trap ... drug development or proteomics researcher. Innovative ... the leaders in mass spectrometry brings ...
Biology Products: